Pmgc (ELAB) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $3.04, +2.36% vs the prior close of $2.97.
- Volume 15.70K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ELAB rises 2.4% to $3.04. Closed at $3.04, +2.36% vs the prior close of $2.97. Day range $2.79–$3.06, opened at $2.94.
ELAB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ELAB rises 2.4% to $3.04
- Closed at $3.04, +2.36% vs the prior close of $2.97. Day range $2.79–$3.06, opened at $2.94.
- Volume was 15.70K shares, 0.3x its 50-day average of 51.02K — lighter than usual.
- Price is -42.8% vs its 50-day average ($5.31) and -94.3% vs its 200-day average ($53.11).
- 52-week range $2.59–$2,112.00; today's close sits at 0% of that range, 99.9% below the 52-week high.
Oct 14, 2026 — ELAB rises 0.3% to $2.97
- Closed at $2.97, +0.34% vs the prior close of $2.96. Day range $2.96–$3.07, opened at $3.01.
- Volume was 11.20K shares, 0.2x its 50-day average of 51.34K — lighter than usual.
- Price is -45.5% vs its 50-day average ($5.45) and -94.6% vs its 200-day average ($54.78).
- 52-week range $2.59–$2,671.20; today's close sits at 0% of that range, 99.9% below the 52-week high.
Oct 13, 2026 — ELAB dips 3.0% to $2.96, a 52-week low, 7 down days in a row
- Closed at $2.96, -2.95% vs the prior close of $3.05. Day range $2.85–$3.06, opened at $3.05.
- Volume was 13.60K shares, 0.3x its 50-day average of 51.50K — lighter than usual.
- Price is -47.0% vs its 50-day average ($5.59) and -94.8% vs its 200-day average ($56.62).
- 52-week range $2.59–$2,671.20; today's close sits at 0% of that range, 99.9% below the 52-week high.
- That makes 7 straight losses.
Oct 12, 2026 — ELAB dips 1.0% to $3.05, a 52-week low, 6 down days in a row
- Closed at $3.05, -0.97% vs the prior close of $3.08. Day range $3.00–$3.14, opened at $3.06.
- Volume was 8.40K shares, 0.2x its 50-day average of 51.78K — lighter than usual.
- Price is -46.6% vs its 50-day average ($5.71) and -94.8% vs its 200-day average ($58.53).
- 52-week range $2.59–$2,671.20; today's close sits at 0% of that range, 99.9% below the 52-week high.
- That makes 6 straight losses.
Oct 9, 2026 — ELAB dips 1.4% to $3.08, a 52-week low, 5 down days in a row
- Closed at $3.08, -1.44% vs the prior close of $3.12. Day range $3.07–$3.12, opened at $3.12.
- Volume was 4.10K shares, 0.1x its 50-day average of 52.36K — lighter than usual.
- Price is -47.2% vs its 50-day average ($5.83) and -94.9% vs its 200-day average ($60.53).
- 52-week range $2.59–$2,671.20; today's close sits at 0% of that range, 99.9% below the 52-week high.
- That makes 5 straight losses.
Oct 8, 2026 — ELAB dips 0.5% to $3.12, a 52-week low, 4 down days in a row
- Closed at $3.12, -0.48% vs the prior close of $3.14. Day range $3.06–$3.34, opened at $3.24.
- Volume was 16.60K shares, 0.3x its 50-day average of 52.78K — lighter than usual.
- Price is -47.6% vs its 50-day average ($5.96) and -95.0% vs its 200-day average ($62.93).
- 52-week range $2.59–$2,671.20; today's close sits at 0% of that range, 99.9% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — ELAB slides 4.0% to $3.14, a 52-week low, 3 down days in a row
- Closed at $3.14, -3.98% vs the prior close of $3.27. Day range $3.12–$3.39, opened at $3.19.
- Volume was 19.90K shares, 0.4x its 50-day average of 53.92K — lighter than usual.
- Price is -48.3% vs its 50-day average ($6.07) and -95.2% vs its 200-day average ($65.62).
- 52-week range $2.59–$2,671.20; today's close sits at 0% of that range, 99.9% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — ELAB ends flat (+0.0%) to $3.27
- Closed at $3.27, +0.00% vs the prior close of $3.27. Day range $3.08–$3.30, opened at $3.23.
- Volume was 14.70K shares, 0.3x its 50-day average of 56.27K — lighter than usual.
- Price is -47.3% vs its 50-day average ($6.20) and -95.2% vs its 200-day average ($68.22).
- 52-week range $2.59–$2,671.20; today's close sits at 0% of that range, 99.9% below the 52-week high.
Oct 5, 2026 — ELAB dips 2.7% to $3.27
- Closed at $3.27, -2.68% vs the prior close of $3.36. Day range $3.06–$3.36, opened at $3.30.
- Volume was 40.90K shares, 0.7x its 50-day average of 56.18K.
- Price is -48.2% vs its 50-day average ($6.32) and -95.4% vs its 200-day average ($70.98).
- 52-week range $2.59–$2,671.20; today's close sits at 0% of that range, 99.9% below the 52-week high.
Oct 2, 2026 — ELAB jumps 4.2% to $3.36
- Closed at $3.36, +4.19% vs the prior close of $3.22. Day range $3.20–$3.45, opened at $3.35.
- Volume was 21.10K shares, 0.4x its 50-day average of 57.22K — lighter than usual.
- Price is -47.8% vs its 50-day average ($6.43) and -95.5% vs its 200-day average ($74.90).
- 52-week range $2.59–$2,671.20; today's close sits at 0% of that range, 99.9% below the 52-week high.
ELAB latest news & SEC filings
Every SEC filing by or about ELAB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.31M
- Net income: -$2.94M (prior year -$562.36K) (loss widened vs Jun 30, 2025)
Jul 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jul 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade ELAB
- How much it moves: over the last 20 sessions the average daily move was 3.99% (largest 23.2%). That is a volatile stock.
- Liquidity: about 54.09K shares (≈$164.45K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.04 vs a range of $2.59–$2,112.00 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Aug 21, 2026, 1:6 on Mar 10, 2026, 1:4 on Jan 6, 2026, 285:1000 on Sep 2, 2025, 1:7 on Mar 10, 2025, 1:200 on Nov 27, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 18, 2026; 8-K Sep 2, 2026; 8-K Aug 27, 2026.
- Share count: 8.10M shares outstanding (Aug 14, 2026), +445.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ELAB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.94 | 3.06 | 2.79 | 3.04 | 15.70K |
| Oct 14, 2026 | 3.01 | 3.07 | 2.96 | 2.97 | 11.20K |
| Oct 13, 2026 | 3.05 | 3.06 | 2.85 | 2.96 | 13.60K |
| Oct 12, 2026 | 3.06 | 3.14 | 3.00 | 3.05 | 8.40K |
| Oct 9, 2026 | 3.12 | 3.12 | 3.07 | 3.08 | 4.10K |
| Oct 8, 2026 | 3.24 | 3.34 | 3.06 | 3.12 | 16.60K |
| Oct 7, 2026 | 3.19 | 3.39 | 3.12 | 3.14 | 19.90K |
| Oct 6, 2026 | 3.23 | 3.30 | 3.08 | 3.27 | 14.70K |
| Oct 5, 2026 | 3.30 | 3.36 | 3.06 | 3.27 | 40.90K |
| Oct 2, 2026 | 3.35 | 3.45 | 3.20 | 3.36 | 21.10K |
| Oct 1, 2026 | 3.54 | 3.54 | 2.59 | 3.22 | 181.70K |
| Sep 30, 2026 | 3.75 | 3.75 | 3.47 | 3.54 | 41.30K |
| Sep 29, 2026 | 4.66 | 4.97 | 3.40 | 3.67 | 201.50K |
| Sep 28, 2026 | 4.54 | 5.56 | 4.53 | 4.78 | 250.70K |
| Sep 25, 2026 | 4.46 | 4.60 | 4.35 | 4.57 | 8.70K |
| Sep 24, 2026 | 4.57 | 4.71 | 4.43 | 4.52 | 11.80K |
| Sep 23, 2026 | 4.34 | 4.64 | 4.32 | 4.53 | 40.00K |
| Sep 22, 2026 | 4.27 | 4.52 | 4.13 | 4.26 | 23.20K |
| Sep 21, 2026 | 4.68 | 4.74 | 4.35 | 4.42 | 21.80K |
| Sep 18, 2026 | 4.56 | 5.07 | 4.56 | 4.78 | 135.00K |
About Pmgc
Pmgc (ELAB) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NEWPORT BEACH, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1840563.
ELAB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Graydon Bensler | Chief Executive Officer | Jun 3, 2026 |
| Lichti Braeden | Director | Jun 2, 2026 |
| Juliana Daley | Director | Jun 2, 2026 |
| George Kovalyov | Director | Jun 2, 2026 |
| Jeffrey Parry | Director | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Graydon Bensler | Chief Executive Officer | Jun 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ELAB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $590.08K | $-7.75M | — | $-5.93M |
| Dec 31, 2024 | — | $-6.25M | — | $-5.49M |
| Dec 31, 2023 | $1.71M | $-4.30M | -0.40 | $-4.56M |
| Dec 31, 2022 | $766.28K | $-1.80M | -0.19 | $-1.59M |
Latest balance sheet: total assets $36.56M, total liabilities $19.83M, cash $3.98M (as of Jun 30, 2026).
ELAB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ELAB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.